SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

News in brief

Xceleron relocating staff from UK to US after cash boost

06-Feb-2012

Xceleron is relocating analytical staff from the UK to Maryland after receiving funds to invest in the US facility.

A $2.4m (€1.8m) investment by Albion Ventures and Solon Ventures will allow Xceleron to install new equipment at its facility in Germantown, Maryland. Xceleron is relocating senior analytical staff from its York, UK site to work with the new capabilities at the Germantown facility.

 

Stuart Best, vice president of analytical operations, said: “The combined ruggedness of AMS and the specificity of the most sensitive LC-MS/MS will enable a highly cost-effective and safe bridge from discovery to the clinic.”

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE